Companies · Other Health Care

Life Boost Inc.

PLYMOUTH · Other Health Care

Diligence memoA one-page analyst read on Life Boost Inc. — recommendation, valuation, rhythm, risks.
$18.8M
Total raised · real
7
Rounds
6.1×
Latest step-up
Top 18%
Sector rank · raised
Series A
Latest stage · inferred · Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Life Boost Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.72× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era.
Dormant
  • Last raise 5.8 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Life Boost Inc. is one of 5376 Other Health Care companies tracked from PLYMOUTH. By capital raised it ranks in the upper tier (ahead of 83% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
24
Investors (latest)
2020-09-08
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2016-04-04 Raised $2.1M (real) Modeled valuation $52M (est)Seed2016Pre-Seed · 2016-04-04 Raised $200K (real) Modeled valuation $6.2M (est)Pre-Seed2016Seed · 2017-09-07 Raised $805K (real) Modeled valuation $20M (est)Seed2017Seed · 2018-03-28 Raised $3.5M (real) Modeled valuation $87M (est)Seed2018Seed · 2019-04-18 Raised $600K (real) Modeled valuation $15M (est)Seed2019Seed · 2019-12-11 Raised $1.1M (real) Modeled valuation $26M (est)Seed2019Seed · 2020-04-14 Raised $1.5M (real) Modeled valuation $37M (est)Seed2020Series A · 2020-09-08 Raised $9.2M (real) Modeled valuation $174M (est)Series A2020+$200K+$805K+$3.5M+$600K+$1.1M+$1.5M+$9.2MCumulative $19M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.1M · 2016
Bridge · Seed-stage$200K · 2016smaller follow-on
Seed extension$805K · 2017
Seed extension$3.5M · 2018
Seed extension$600K · 2019
Seed extension$1.1M · 2019
Seed extension$1.5M · 2020
Series A$9.2M · 2020

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$173.8M
Base estimate est.
$11.8M
Conservative case
$904.5M
Upside case
$41.9M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $52.0M · 2016-04-042016Pre-Seed · modeled $6.2M · 2016-04-04Seed · modeled $20.0M · 2017-09-07Seed · modeled $86.7M · 2018-03-28Seed · modeled $14.9M · 2019-04-18Seed · modeled $26.0M · 2019-12-11Seed · modeled $37.2M · 2020-04-14Series A · modeled $173.8M · 2020-09-082020
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
5.8 yr
Elapsed time used
5.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
8 mo
Avg between rounds
$4.2M/yr
Capital velocity
10.2 yr
On record since
2016
First round
8
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 7.7× above median
This company$18.8M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.6× above median
This company$9.2M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 7.9× above median
This company$173.8M
Sector median$22.1M

Raised more than 83% of sector peers (real $). Modeled value above 86% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #25 of 164.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)iVinci Partners, LLC · Series A Raised $34.8M · modeled $302.7M (est)InvestCo Tabletop, LLC · Series A Raised $15.0M · modeled $302.7M (est)Mediphore, Inc. · Series A Raised $15.0M · modeled $302.7M (est)Oklahoma Proton Center LLC · Series A Raised $14.0M · modeled $282.5M (est)MicroOptx, Inc. · Series A Raised $17.8M · modeled $278.6M (est)ProxsysRx, Inc. · Series A Raised $14.6M · modeled $259.8M (est)Biolux Research Holdings, Inc. · Series A Raised $12.7M · modeled $256.3M (est)Fountain Life Holdings, LLC · Series A Raised $17.1M · modeled $238.4M (est)Equality Management Holdings, LLC · Series A Raised $14.4M · modeled $232.1M (est)Olympus Ascent Investors, LLC · Series A Raised $11.5M · modeled $232.0M (est)EDS Holdco LLC · Series A Raised $12.3M · modeled $221.3M (est)Zipari, Inc. · Series A Raised $29.6M · modeled $208.3M (est)Life Boost Inc. (this company) Raised $18.8M · modeled $173.8M (est)Life Boost Inc.
CompanyStageRaised · realValue · estvs peer med.
iVinci Partners, LLCSeries A$34.8M$302.7M3.00×
InvestCo Tabletop, LLCSeries A$15.0M$302.7M3.00×
Mediphore, Inc.Series A$15.0M$302.7M3.00×
Oklahoma Proton Center LLCSeries A$14.0M$282.5M2.80×
MicroOptx, Inc.Series A$17.8M$278.6M2.76×
ProxsysRx, Inc.Series A$14.6M$259.8M2.57×
Biolux Research Holdings, Inc.Series A$12.7M$256.3M2.54×
Fountain Life Holdings, LLCSeries A$17.1M$238.4M2.36×
Equality Management Holdings, LLCSeries A$14.4M$232.1M2.30×
Olympus Ascent Investors, LLCSeries A$11.5M$232.0M2.30×
EDS Holdco LLCSeries A$12.3M$221.3M2.19×
Zipari, Inc.Series A$29.6M$208.3M2.06×
Life Boost Inc. this companySeries A$18.8M$173.8M1.72×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.1M2016-04-04$10.5M$52.0M90%
Pre-Seed$200K2016-04-04$1.1M$6.2M85%
Seed$805K2017-09-07$4.0M$20.0M90%
Seed$3.5M2018-03-28$17.5M$86.7M90%
Seed$600K2019-04-18$3.0M$14.9M90%
Seed$1.1M2019-12-11$5.3M$26.0M90%
Seed$1.5M2020-04-14$7.5M$37.2M90%
Series A$9.2M2020-09-08$41.9M$173.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.1M2016-04-04
    • First recorded raise — entered as Seed.
    • 16 investors on this round.
  2. Pre-Seed$200K2016-04-04
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 10.5× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  3. Seed$805K2017-09-07
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 4.0× larger than the prior — scaling up.
    • 14 investors on this round.
  4. Seed$3.5M2018-03-28
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 4.3× larger than the prior — scaling up.
    • 22 investors on this round.
  5. Seed$600K2019-04-18
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 5.8× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  6. Seed$1.1M2019-12-11
    • Came back fast: 8 mo vs the ~14 mo sector norm.
    • Round 1.8× larger than the prior — scaling up.
    • 4 investors on this round.
  7. Seed$1.5M2020-04-14
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 1.4× larger than the prior — scaling up.
    • 1 investor on this round.
  8. Series A$9.2M2020-09-08
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 6.1× larger than the prior — scaling up.
    • 24 investors on this round.
Intelligence
2021 ~Q2
Modeled next raise · ~8mo cadence
$27.7M
Modeled next size est.range $18.0M$44.3M
6.1×
Last step-up
$4.2M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Roger Newton3 other2018-03
Robert Verdun2 other2016-04
Greg McParland1 other2018-03
Julian Reis1 other2016-04
Ted Mills1 other2016-04
Thomas Copeman1 other2016-04
Chase Linton2016-04
Jacob Fenton2018-03
Jeff Linton2016-04
Mike Bush2019-04
Registry & provenance

Life Boost Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1672293
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Tespo Health Holdings, LLCHealthtechSeries A$6.9M$37.1Mnetwork2 shared operators · same stage
Cartiva, Inc.Other Health CareSeries A$18.8M$141.3Msame sector · same stage
SafeTraces, Inc.Other Health CareSeries A$19.0M$201.8Msame sector · same stage
Nfocus Neuromedical, Inc.Other Health CareSeries A$18.5M$152.2Msame sector · same stage
Myca Health Inc.Other Health CareSeries A$19.2M$209.0Msame sector · same stage
Informed Medical Decisions, Inc.Other Health CareSeries A$19.2M$131.2Msame sector · same stage
Tepha IncOther Health CareSeries A$19.3M$229.0Msame sector · same stage
SmartyPants, Inc.Other Health CareSeries A$19.3M$136.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Life Warmer, Inc.Other Health CareSeed$30.1M90%
Aveta.Life Inc.Other Health CareSeed$41.3M89%
Better Life Partners Inc.Other Health CareSeries B$231.8M88%
LifeCouple, Inc.Other Health CarePre-Seed$6.2M88%
LifeSpeak Inc.Other Health CareSeries B$2.3M88%
Resilient Lifescience, Inc.Other Health CarePre-Seed$5.5M86%
Lifespark Holdings, Inc.Other Health CareSeries B$261.5M86%
UE LifeSciences Inc.Other Health CarePre-Seed$7.5M86%
Frequently asked
How much funding has Life Boost Inc. raised?
Life Boost Inc. has raised approximately $18.8M in disclosed capital across 7 recorded financing rounds, aggregated from public filings.
What is Life Boost Inc.'s estimated valuation?
Provath's modeled valuation for Life Boost Inc. is approximately $173.8M (modeled range $11.8M–$904.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Life Boost Inc. at?
Life Boost Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Tue Sep 08.
What does Life Boost Inc. do and where is it based?
Life Boost Inc. operates in the Other Health Care sector, based in PLYMOUTH.
Explore related

See where Life Boost Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Life Boost Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.